VIE/NVAX (VIE/NVAX)

Vienna Stock Exchange: VIE/NVAX · EUR

€9.32

+0.17 (+1.9%)· Recorded snapshot

Market cap	1.5B
Revenue (ttm)	362.2M
Net income (ttm)	-216.8M
EPS (ttm)	-€1.36
Volume	848

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 362.2M
Net income (ttm): -216.8M
EPS (ttm): -€1.36
Market cap: 1.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROEn/a

P25 4.8P50 10.6P75 20.1

ROIC-18

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/NVAX indicators

Market & fundamental data

Available fields

162

Groups with data

Currency

USD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-11-05
Employees	749
Employees change	-203
Employees growth	-21.32%
Enterprise value	EUR 1.2B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1987
Industry	Biotechnology
Is primary listing	No
ISIN number	US6700024010
Last earnings date	2026-08-06
Last refreshed	2026-10-30
Market cap	EUR 1.5B
Next earnings date	2026-11-05
Price	EUR 9.32
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/NVAX
Website	https://www.novavax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.55%
EV/Sales	3.15x
FCF / EV yield	-3.16%
FCF yield	-2.39%
P/S ratio	4.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-28.85%
EBITDA margin	-24.54%
Gross margin	-2.56%
Operating margin	-28.85%
Pretax margin	-59.28%
Profit margin	-59.87%
Profit per employee	EUR -289,503
Profitable years	1
Revenue per employee	EUR 483,572
ROA	-6.51%
ROA (5Y)	-13.46%
ROCE	-19.1%
ROIC	-18.01%
SBC / revenue	7.81%
Tax / revenue	0.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Net income growth years	4
Revenue growth	-61.64%
Revenue growth (Q)	-76.3%
Revenue growth (QoQ)	-59.36%
Revenue growth 10Y	36.01%
Revenue growth 3Y	-36.25%
Revenue growth 5Y	-18.93%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -4.6M
Depreciation and amortization	EUR 15.9M
EBIT	EUR -104.5M
EBITDA	EUR -88.9M
EPS	EUR -1.36
Financing cash flow	EUR 65.4M
Free cash flow	EUR -36.9M
Free cash flow minus SBC	EUR -65.2M
Gross profit	EUR -9.3M
Income taxes	EUR 2.1M
Investing cash flow	EUR -95.9M
Net borrowing	EUR 72M
Net cash flow	EUR -63.8M
Net income	EUR -216.8M
Operating cash flow minus SBC	EUR -60.6M
Operating income	EUR -104.5M
Revenue	EUR 362.2M
Stock-based compensation	EUR 28.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.5
Book value per share	EUR -1.01
Goodwill	EUR 100.5M
Interest coverage	-5.2
Long-term assets	EUR 147.8M
Long-term liabilities	EUR 708.1M
Net cash (debt)	EUR 369.4M
Net cash / market cap	23.88%
Net cash growth	9.95%
Piotroski F-Score	1
Property, plant and equipment	EUR 51.8M
Shareholders' equity	EUR -166.9M
Tangible book value	EUR -265.4M
Tangible book value per share	EUR -1.61
Total assets	EUR 836.4M
Total cash	EUR 629.6M
Total debt	EUR 260.2M
Total liabilities	EUR 1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current assets	EUR 688.6M
Current liabilities	EUR 295.2M
Current ratio	2.33
Inventory turnover	41.92
Net working capital	EUR -240.5M
Quick ratio	2.23
Working capital	EUR 385.6M
Working capital turnover	0.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.06%
Shareholder yield	3.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 8.07
1D price change	1.86%
1M price change	1.86%
1M total return	1.86%
1W price change	0.76%
1W total return	0.76%
1Y price change	26.6%
1Y return CAGR	26.62%
1Y total return	26.6%
20-day SMA	EUR 10.02
200-day SMA	EUR 8.06
3M price change	44.95%
3M total return	44.95%
50-day SMA	EUR 9.13
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 11.82
52-week high date	2026-10-14
52-week low	EUR 5.41
52-week low date	2025-11-21
6M price change	37.26%
6M total return	37.26%
All-time high	EUR 13.35
All-time high date	2024-10-04
All-time low	EUR 4.71
All-time low date	2025-04-10
Average true range (ATR)	EUR 0.55
Average volume	1.4K
Change from 52-week high	-21.15%
Change from 52-week low	72.4%
Change from all-time high	-30.19%
Change from all-time low	98.05%
Change from open	2.31%
Day's gap	-0.44%
Dollar volume	EUR 7,903
High price	EUR 9.41
Low price	EUR 9.11
Monthly RSI	48.12
Open price	EUR 9.11
Position in 52-week range	70%
Previous close	EUR 9.15
Price vs 150-day SMA	15.45%
Price vs 20-day SMA	-6.96%
Price vs 200-day SMA	15.68%
Price vs 50-day SMA	2.13%
Relative volume	0.6
RSI	47.21
Sharpe ratio	0.63
Sortino ratio	1.14
Volume	848
Weekly RSI	55.7
YTD price change	60.58%
YTD total return	60.58%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	146.2M
Shares change (QoQ)	0.79%
Shares change (YoY)	-3.06%
Shares held by insiders	0.79%
Shares held by institutions	58.89%
Short ratio	7.6 days

Deeper analysis on VIE/NVAX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/NVAX report

Is a complete VIE/NVAX research report available?

No complete published report is available for vie/NVAX (VIE/NVAX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/NVAX (VIE/NVAX)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/NVAX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/NVAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/NVAX

Frequently asked questions